CURRENT PHARMACEUTICAL BIOTECHNOLOGY is a prestigious academic journal dedicated to advancing the field of pharmaceutical biotechnology by publishing high-quality research articles, reviews, and innovatory methodologies. Published by Bentham Science Publishers Ltd, this journal has established a strong reputation in its field, reflected in its 2023 Scopus rankings: it holds an impressive Q2 classification in Pharmaceutical Science and Q3 in Biotechnology, indicating its significant impact within these disciplines. With an ISSN of 1389-2010 and an E-ISSN of 1873-4316, CURRENT PHARMACEUTICAL BIOTECHNOLOGY provides a reliable platform for disseminating valuable research findings and fostering collaboration among researchers, professionals, and students alike. The journal covers a wide array of topics, from drug development and delivery systems to innovative biotechnological techniques, thus serving as an essential resource for anyone interested in the cross-section of pharmaceutical science and biotechnology. Researchers can access a diverse range of articles that explore both theoretical frameworks and practical applications, reflecting the ongoing evolution and challenges in this dynamic field.

Natural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.

Archives of Pharmacal Research, published by the Pharmaceutical Society of Korea, is a leading journal in the fields of drug discovery, molecular medicine, and organic chemistry. With an illustrious history spanning from 1978 to 2024, this peer-reviewed journal has earned a remarkable reputation, achieving a Q1 category ranking in each of its primary research areas as of 2023. Ranked #9 in Organic Chemistry and #12 in Drug Discovery among their respective fields, Archives of Pharmacal Research showcases cutting-edge research that contributes significantly to scientific advancements. Although it is not an open-access journal, its impactful publications are crucial resources for researchers, professionals, and students navigating the complexities of pharmacological sciences. The journal's continued commitment to disseminating high-quality research underlines its importance in fostering innovation and expanding knowledge within the pharmaceutical landscape.

Fitoterapia is a prestigious journal published by Elsevier that specializes in the fields of drug discovery and pharmacology. Established in 1948 and featuring a comprehensive scope that encompasses all aspects of medicinal plants and their derivatives, this journal is a critical resource for researchers, professionals, and students interested in the pharmacological effects of natural products. With an impressive impact factor reflected in its Q2 ranking in both Drug Discovery and Medicine as well as a Q3 ranking in Pharmacology, Fitoterapia plays a vital role in promoting innovative research in the intersection of traditional medicine and modern pharmacological science. The journal’s commitment to quality is further highlighted by its rankings in Scopus, where it holds a notable position among peers in its field. Although Fitoterapia does not currently offer Open Access, its reputation for rigor and relevance makes it an indispensable asset for anyone engaged in herbal medicine research and development. Authors and researchers seeking to publish groundbreaking findings will find a welcoming platform to disseminate their work in this influential journal.

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

Natural Products Journal, a leading publication by Bentham Science Publishers, primarily focuses on the rapidly evolving field of Natural Products and their applications in Complementary and Alternative Medicine as well as Drug Discovery. With an ISSN of 2210-3155 and an E-ISSN of 2210-3163, this journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the critical role of natural compounds in health and medicine. Since its inception in 2011, it has consolidated its reputation, achieving a Q3 ranking in Complementary and Alternative Medicine and a Q4 ranking in Drug Discovery as of 2023, illustrating its growing influence within the academic community. Although it currently does not operate as an Open Access journal, it remains a vital resource for cutting-edge research and developments in natural products, offering insightful contributions that pave the way for innovative therapeutic strategies. Located in the Netherlands, the journal is pivotal for those looking to stay at the forefront of research in natural substances and their multifaceted applications.

Avicenna Journal of Phytomedicine, published by Mashhad University of Medical Sciences, is a premier Open Access journal dedicated to advancing the field of phytomedicine. Established in 2011, this journal aims to promote research on the therapeutic potentials of medicinal plants, integrating traditional knowledge with modern pharmacological insights. With an ISSN of 2228-7930 and an E-ISSN of 2228-7949, it has garnered significant attention in the research community, achieving a Q2 ranking in Complementary and Alternative Medicine and a Q3 ranking in Drug Discovery as of 2023. Its Scopus rankings affirm the journal's relevance, with the journal positioned at 37 out of 105 in its category, reflecting a 65th percentile. The Avicenna Journal of Phytomedicine serves as an invaluable resource for researchers, professionals, and students seeking to explore innovative botanical therapies, making it a notable platform for disseminating high-quality research in this burgeoning field.

PHYTOMEDICINE is a premier journal published by Elsevier GmbH, based in Germany, that serves as a central hub for the dissemination of innovative research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Pharmaceutical Science, and Pharmacology. Established in 1994, this multidisciplinary journal has rapidly ascended to a Q1 ranking across these categories in 2023, highlighting its significance and impact within the scientific community. With its current Scopus rankings placing it in the top tiers—such as #3 in Complementary and Alternative Medicine and #17 in Pharmaceutical Science—PHYTOMEDICINE is recognized for its commitment to publishing high-quality, peer-reviewed articles that advance our understanding of phytotherapeutics and their applications. Researchers and professionals in the field benefit from its rigorous standards and comprehensive coverage, while students gain access to essential findings that shape contemporary practices in medicine and pharmacology. Its continued focus on critical advancements ensures that PHYTOMEDICINE remains a vital resource for anyone involved in the exploration of medicinal plants and their potential health benefits.

Annals of Phytomedicine - An International Journal is a leading publication dedicated to the exploration and advancement of phytomedicine, broadly encompassing research on medicinal plants, their bioactive compounds, and therapeutic applications. Published by UKAAZ Publications, this journal seeks to bridge the gap between traditional and modern medicinal practices, offering a platform for researchers, professionals, and students passionate about herbal therapies and their efficacy. With an ISSN 2393-9885 and E-ISSN 2278-9839, the journal adheres to stringent peer-review protocols to ensure the publication of high-quality research. Fostering open access to knowledge in a rapidly evolving field, Annals of Phytomedicine serves as an essential resource, promoting innovative findings and comprehensive reviews that drive the global discourse on phytotherapy. By engaging with this journal, readers can stay informed about the latest advancements, contributing significantly to the scholarly community and beyond.

Pakistan Journal of Pharmaceutical Sciences, published by the University of Karachi, serves as a vital platform for advancing research in the field of pharmaceutical sciences. With a strong commitment to disseminating innovative findings and critical studies since its inception in 1995, the journal focuses on a wide array of topics including pharmacology, toxicology, and pharmaceutics. With an ISSN of 1011-601X, it holds a reputable position within the academic community, reflecting its Q3 category ranking in Pharmaceutical Science as of 2023. While the journal is currently not designated as Open Access, it remains accessible through institutional subscriptions, ensuring that both emerging and established researchers can contribute to and benefit from its scholarly content. This publication not only promotes scientific dialogue but also aims to bridge the gap between academia and industry, appealing to a diverse audience of researchers, professionals, and students seeking to stay informed about the latest advancements and trends in pharmaceutical research.